Quarterly Result14 Aug 2026, 06:39 pm
ANG Lifesciences declares Q1 FY27 unaudited results
AI Summary
ANG Lifesciences India Ltd has announced the submission of its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results, along with the Limited Review Report, during a meeting held on August 14, 2026. The financial results were reviewed by the Audit Committee prior to board approval. The filing indicates that the results pertain to the first quarter of the fiscal year 2027.
Key Highlights
- Standalone and consolidated unaudited results declared for Q1 FY27.
- Results approved by the Board of Directors on August 14, 2026.
- Limited Review Report for the quarter also submitted.
- Audit Committee reviewed the financial results.
- Results pertain to the quarter ended June 30, 2026.
Price Impact
More from ANG